⚠️ No article content returned.
Boston Scientific Corporation (BSX)
- Written by: Madison Wilson
Latest Company News
RTW Biotech Opportunities Ltd announces that Boston Scientific Corporation has agreed to acquire Penumbra, Inc., a public portfolio company, in a transaction valued at $14.5 billion.
